Please login to the form below

Not currently logged in
Email:
Password:

health technology assessments

This page shows the latest health technology assessments news and features for those working in and with pharma, biotech and healthcare.

Promoting off-label use: where to draw the line?

Promoting off-label use: where to draw the line?

public health risk, compassionate use for groups of patients or for individual patients on a named basis. ... The approach put forward by the report undermines both the EU regulatory system for approving medicines and the national pricing and

Latest news

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    with the Department of Health around the PPRS.”. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Genesis Research: What is EVID AI? Genesis Research: What is EVID AI?

    Genesis Research, the leading Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) company, announces new enhancements to EVID AI, the world’s largest current healthcare literature research platform, ... Healthcare stakeholders

  • Accelerating HTA and payer submissions: how digital connectivity is driving faster patient access Accelerating HTA and payer submissions: how digital connectivity is driving faster patient access

    of health technology assessments (HTA) and payer submissions for pharma. ... The road to health technology assessments and payer submissions is paved with complexity.

  • Briggids Limited

    Briggids is a dynamic, global organisation with extensive experience in systematic reviews, health technology assessments, therapeutic value propositions/market access, landscape mapping and medical communications.

  • Can rare diseases be a viable option for the pharma industry?

    In an environment where a successful Health Technology Assessment (HTA), showing substantial benefit over the current standard of care, will become a requirement for any new drug approval post 2014, orphan ... Department of Health &Human Services, Office

  • Fishawack Health Fishawack Health

    Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with ... of health technology

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...